ONY Biotech Inc. – Trademark Portfolio

Entity Type: 03

ONY Biotech Inc. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 10 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 10 trademarks are registered and 1 is pending. Notable registered marks include AERVIA, INFASURF, PUSH PULL, AEROBONNET, and ONYBIOTECH. The owner is based in Amherst, NY.

1576 Sweet Home Road

Amherst, NY 14228

17 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ONY Biotech Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (10 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ONY Biotech Inc. have?

ONY Biotech Inc. has 17 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 pending, 6 abandoned.

What trademark classes does ONY Biotech Inc. file in?

ONY Biotech Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are ONY Biotech Inc.'s most well-known trademarks?

ONY Biotech Inc.'s registered trademark portfolio includes well-known marks such as AERVIA, INFASURF, PUSH PULL, AEROBONNET, and ONYBIOTECH. These are among 10 currently registered trademarks in the portfolio.

What is ONY Biotech Inc.'s trademark registration success rate?

ONY Biotech Inc. has a 63% trademark registration rate, with 10 out of 16 resolved applications resulting in successful registration. Currently, 1 application is pending review.